Coppell Advisory Solutions LLC Vigil Neuroscience, Inc. Transaction History

Coppell Advisory Solutions LLC

  • $680 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$4.8 - $9.92 $11,760 - $24,304
-2,450 Reduced 98.63%
34 $5.16 Million
Q2 2023

Aug 17, 2023
SELL
$8.11 - $10.54 $6,601 - $8,579
-814 Reduced 24.68%
2,484 $399 Million
Q1 2023

May 19, 2023
BUY
$8.77 - $12.7 $26,292 - $38,074
2,998 Added 999.33%
3,298 $502 Million
Q4 2022

May 19, 2023
BUY
$8.74 - $15.99 $2,622 - $4,797
300 New
300 $45.6 Million

Others Institutions Holding VIGL

# of Institutions
52
Shares Held
27.9M
Call Options Held
0
Put Options Held
0
View Full List

About Vigil Neuroscience, Inc.

VIGL Quotes by TradingView
  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $54.6M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email